GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $99,000 | -24.4% | 281,597 | 0.0% | 0.00% | – |
| Q2 2016 | $131,000 | -62.9% | 281,597 | +8.5% | 0.00% | -100.0% |
| Q1 2016 | $353,000 | -7.3% | 259,427 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $381,000 | -7.1% | 259,427 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $410,000 | -1.2% | 259,427 | +6.3% | 0.00% | 0.0% |
| Q2 2015 | $415,000 | +71.5% | 244,089 | +40.4% | 0.00% | – |
| Q1 2015 | $242,000 | -2.8% | 173,839 | +5.3% | 0.00% | – |
| Q4 2014 | $249,000 | -26.8% | 165,118 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $340,000 | -32.7% | 165,118 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $505,000 | +5.9% | 165,118 | -13.4% | 0.00% | 0.0% |
| Q1 2014 | $477,000 | -33.9% | 190,604 | +31.0% | 0.00% | -50.0% |
| Q4 2013 | $722,000 | +106.3% | 145,554 | -5.6% | 0.00% | +100.0% |
| Q3 2013 | $350,000 | +47.1% | 154,241 | +44.1% | 0.00% | 0.0% |
| Q2 2013 | $238,000 | – | 107,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |